Laser Acupuncture Versus Liraglutide in Treatment of Obesity: A Multi-Institutional Retrospective Cohort Study

Overview

Journal Healthcare (Basel)

Specialty Health Services

Date 2024 Jul 13

PMID 38998814

Authors

Wen-Lin Yu

Yu-Ning Liao

Tsung-Hsien Yang

Ching-Wei Yang

Ting-I Kao

Pai-Wei Lee

Chiu-Yi Hsu

Jhen-Ling Huang

Yu-Tung Huang

Hsing-Yu Chen

Affiliations

Soon will be listed here.

Abstract

Background: Obesity is a global concern, driving the search for alternative treatments beyond lifestyle changes and medications. Laser acupuncture (LA) shows promise in obesity management, yet few studies compare it with FDA-approved medications. This study aimed to assess and compare LA's impact with liraglutide on weight reduction in obese individuals.

Methods: Data from the Chang Gung Research Database (CGRD) (2013-2018) were analyzed. Primary outcomes included changes in body weight and BMI within 180 days, with secondary outcomes measuring the proportion achieving 5%, 10%, and 15% weight loss. Adverse events were also assessed.

Results: Of 745 subjects (173 LA users, 572 liraglutide users), LA users lost more weight by day 180 (5.82 ± 4.39 vs. 2.38 ± 5.75 kg; < 0.001) and had a greater BMI reduction (-2.27 ± 1.73 vs. -0.93 ± 2.25 kg/m; < 0.001). More LA users achieved 5% and 10% weight loss compared to liraglutide users (64.2% vs. 22.7%, 26.6% vs. 4.2%; all < 0.001). After balancing baseline differences, LA's benefits remained significant. No adverse events were reported with LA.

Conclusions: LA may offer superior weight reduction compared to liraglutide. Future studies should explore LA alone or in combination with liraglutide for obesity management.

References

Ryan D, Yockey S . Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over. Curr Obes Rep. 2017; 6(2):187-194. PMC: 5497590. DOI: 10.1007/s13679-017-0262-y. View

AlBashtawi J, Al-Jaber H, Ahmed S, Al-Mansoori L . Impact of Obesity-Related Endoplasmic Reticulum Stress on Cancer and Associated Molecular Targets. Biomedicines. 2024; 12(4). PMC: 11047871. DOI: 10.3390/biomedicines12040793. View

Shao S, Lai E, Huang T, Hung M, Tsai M, Yang Y . The Chang Gung Research Database: Multi-institutional real-world data source for traditional Chinese medicine in Taiwan. Pharmacoepidemiol Drug Saf. 2021; 30(5):652-660. DOI: 10.1002/pds.5208. View

Sato T, Ida T, Nakamura Y, Shiimura Y, Kangawa K, Kojima M . Physiological roles of ghrelin on obesity. Obes Res Clin Pract. 2014; 8(5):e405-13. DOI: 10.1016/j.orcp.2013.10.002. View

Heymsfield S, Wadden T . Mechanisms, Pathophysiology, and Management of Obesity. N Engl J Med. 2017; 376(3):254-266. DOI: 10.1056/NEJMra1514009. View

Hu W, Chang C, Hung Y . Clinical observations on laser acupuncture in simple obesity therapy. Am J Chin Med. 2010; 38(5):861-7. DOI: 10.1142/S0192415X10008305. View

Namazi N, Khodamoradi K, Larijani B, Ayati M . Is laser acupuncture an effective complementary therapy for obesity management? A systematic review of clinical trials. Acupunct Med. 2017; 35(6):452-459. DOI: 10.1136/acupmed-2017-011401. View

Naslund E, Gutniak M, Skogar S, Rossner S, Hellstrom P . Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men. Am J Clin Nutr. 1998; 68(3):525-30. DOI: 10.1093/ajcn/68.3.525. View

Curioni C, Lourenco P . Long-term weight loss after diet and exercise: a systematic review. Int J Obes (Lond). 2005; 29(10):1168-74. DOI: 10.1038/sj.ijo.0803015. View

10.

Sebayang R, Aditya C, Abdurrohim K, Lauwrence B, Mihardja H, Kresnawan T . Effects of Laser Acupuncture and Dietary Intervention on Key Obesity Parameters. Med Acupunct. 2020; 32(2):108-115. PMC: 7187979. DOI: 10.1089/acu.2019.1398. View

11.

Fung Lam T, Lyu Z, Wu X, Wong Y, Cao P, Wong E . Electro-acupuncture for central obesity: a patient-assessor blinded, randomized sham-controlled clinical trial. BMC Complement Med Ther. 2024; 24(1):62. PMC: 10823622. DOI: 10.1186/s12906-024-04340-5. View

12.

Chen S, Ho C, Lin W, Lee C, Chen Y, Chen J . The Characteristics and Mortality of Chinese Herbal Medicine Users among Newly Diagnosed Inoperable Huge Hepatocellular Carcinoma (≥10 cm) Patients: A Retrospective Cohort Study with Exploration of Core Herbs. Int J Environ Res Public Health. 2022; 19(19). PMC: 9564474. DOI: 10.3390/ijerph191912480. View

13.

Mulhisen L, Rogers J . Complementary and alternative modes of therapy for the treatment of the obese patient. J Am Osteopath Assoc. 2000; 99(10 Su Pt 2):S8-12. View

14.

Zeng B, Zeng B, Chen Y, Hung C, Sun C, Cheng Y . Efficacy and acceptability of noninvasive brain stimulation interventions for weight reduction in obesity: a pilot network meta-analysis. Int J Obes (Lond). 2021; 45(8):1705-1716. DOI: 10.1038/s41366-021-00833-2. View

15.

Karra P, Winn M, Pauleck S, Bulsiewicz-Jacobsen A, Peterson L, Coletta A . Metabolic dysfunction and obesity-related cancer: Beyond obesity and metabolic syndrome. Obesity (Silver Spring). 2022; 30(7):1323-1334. PMC: 9302704. DOI: 10.1002/oby.23444. View

16.

Fang S, Wang M, Zheng Y, Zhou S, Ji G . Acupuncture and Lifestyle Modification Treatment for Obesity: A Meta-Analysis. Am J Chin Med. 2017; 45(2):239-254. DOI: 10.1142/S0192415X1750015X. View

17.

Williams D, Baskin D, Schwartz M . Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety. Endocrinology. 2008; 150(4):1680-7. PMC: 2659282. DOI: 10.1210/en.2008-1045. View

18.

Martinez B, Peplow P . Treatment of insulin resistance by acupuncture: a review of human and animal studies. Acupunct Med. 2016; 34(4):310-9. DOI: 10.1136/acupmed-2016-011074. View

19.

Valenzuela P, Carrera-Bastos P, Castillo-Garcia A, Lieberman D, Santos-Lozano A, Lucia A . Obesity and the risk of cardiometabolic diseases. Nat Rev Cardiol. 2023; 20(7):475-494. DOI: 10.1038/s41569-023-00847-5. View

20.

Wozniak P, Stachowiak G, Pieta-Dolinska A, Oszukowski P . Laser acupuncture and low-calorie diet during visceral obesity therapy after menopause. Acta Obstet Gynecol Scand. 2003; 82(1):69-73. DOI: 10.1034/j.1600-0412.2003.820113.x. View